Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus - a retrospective nationwide study-Reference-Cited by-同舟云学术

Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus - a retrospective nationwide study

Published:2014-06-09 Issue:10 Volume:16 Page:1001-1008
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Mogensen U. M.¹,Andersson C.²,Fosbøl E. L.¹,Schramm T. K.³,Vaag A.⁴,Scheller N. M.⁵,Torp-Pedersen C.⁵,Gislason G.²⁶⁷,Køber L.¹

Affiliation:

1. Department of Cardiology; University Hospital Rigshospitalet; Copenhagen Denmark

2. Department of Cardiology; University Hospital Gentofte; Copenhagen Denmark

3. Department of Cardiology; University Hospital Frederiksberg; Copenhagen Denmark

4. Department of Endocrinology; University Hospital Rigshospitalet; Copenhagen Denmark

5. Department of Health Science and Technology; Aalborg University; Aalborg Denmark

6. Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen Denmark

7. National Institute of Public Health; University of Southern Denmark; Copenhagen Denmark

Funder

Interreg IVA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12314/fullpdf

Reference38 articles.

1. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetologia,2012

2. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group;Turner;JAMA,1999

3. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

4. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials;Lamanna;Diabetes Obes Metab,2011

5. Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials;Boussageon;PLoS Med,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three-step matching algorithm to enhance between-group comparability and minimize confounding in comparative effectiveness studies;Scientific Reports;2022-01-07

2. Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies;Nutrition, Metabolism and Cardiovascular Diseases;2021-06

3. Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy;Medicine;2021-03-05

4. Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort study;Diabetes, Obesity and Metabolism;2021-02-10

5. Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?;Pharmaceuticals;2020-11-27